secwatch.observer — SEC 8-K summary
======================================

Issuer:     ICU MEDICAL INC/DE (ICUI)
CIK:        0000883984
Form:       8-K
Filed at:   2024-08-07T23:59:59+00:00
Accession:  0000883984-24-000028
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ICU Medical Q2 revenue up 8.6% to $596.5M but GAAP net loss widens to $21.4M; adjusted EPS down to $1.56
--------------------------------------------------------------------------------

- Revenue $596.5M up 8.6% YoY from $549.3M; GAAP gross margin 35% unchanged.
- GAAP net loss $(21.4)M ($0.88 loss per diluted share) vs $(9.9)M loss ($0.41) in Q2 2023.
- Adjusted diluted EPS $1.56 vs $1.88 YoY; adjusted EBITDA $91.3M down from $98.1M.
- Fiscal 2024 guidance updated; details not included in this excerpt.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/883984/000088398424000028/0000883984-24-000028-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/883984/000088398424000028/icui-20240807.htm
  HTML page:      https://secwatch.observer/filing/0000883984-24-000028

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer